Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adele Madelyn Gulfo Insider Profile
4 Followers
Adele Madelyn Gulfo, Director at Medexus Pharmaceuticals Inc, holds 54.93K shares in Medexus Pharmaceuticals Inc (Ticker: TSE:MDP).
Adele Madelyn Gulfo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Adele Madelyn Gulfo's holdings
Insider Roles
Director
Roles that Adele Madelyn Gulfo holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Adele Madelyn Gulfo
Adele Madelyn Gulfo's Trading History
List of latest transactions for each holding click on a transaction to see Adele Madelyn Gulfo's performance on stock
You May Also Like
Adele Madelyn Gulfo insider profile FAQ
What is the percentage of profitable transactions made by Adele Madelyn Gulfo?
The percentage of profitable transactions made by Adele Madelyn Gulfo is ―.
What is the average return per transaction made by Adele Madelyn Gulfo?
The average return per transaction made by Adele Madelyn Gulfo is ―.
What stocks does Adele Madelyn Gulfo hold?
Adele Madelyn Gulfo holds: TSE:MDP stocks.
What was Adele Madelyn Gulfo’s latest transaction?
Adele Madelyn Gulfo latest transaction was an Uninformative Sell of C$49.64K.
What was Adele Madelyn Gulfo's most profitable transaction?
Adele Madelyn Gulfo’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Adele Madelyn Gulfo's role in Medexus Pharmaceuticals Inc?
Adele Madelyn Gulfo's role in Medexus Pharmaceuticals Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.